Arthramid® for
Equine

A UNIQUE SOLUTION FOR
JOINT LAMENESS AND OSTEOARTHRITIS
Arthramid for veterinarians

Advanced Joint Treatment Backed by
Over 25 Years of Research

Arthramid® is a clinically proven, long-lasting treatment for osteoarthritis that helps restore comfort and performance in horses. Administered through intra-articular joint injection, it is integrated into the synovium of the joint, improving function and resolving lameness.

Find A Distributor

Why Leading Veterinarians Trust Arthramid

Key Clinical Outcomes:
  • Proven to reduce lameness in both early and late stages of OA
  • Long-lasting results, often maintained beyond 12 months
  • Targets synovitis at its source to help slow disease progression
  • Supported by published clinical studies across human and animal disciplines

Arthramid intervenes in the osteoarthritis process by enhancing synovial membrane integrity and restoring capsular elasticity.

Find A Distributor

Ideal Candidates for Arthramid

Early-Stage Intervention: Synovitis and early osteoarthritis before cartilage degradation becomes irreversible.

Late-Stage Management: Horses non-responsive to conventional therapies including corticosteroids, hyaluronic acid, or IRAP.

Performance Horse Medicine: Minimal withdrawal time makes it suitable for competition horses across all disciplines.

Find A Distributor

Explore Additional Educational Equine Arthramid Resources

Arthramid equine
Treatment Guides
Clinical Studies
Dr Leigh deClifford
Courses & Events

Testimonials

Dr Dan Carter
Dr. Dan Carter
COUNTRYSIDE VETERINARY HOSPITAL - COVINGTON, GA
“Arthramid is a game changer for all equine athletes. It all starts in the synovium with synovitis and capsulitis, before we get to osteoarthritis. I routinely tell my horse owners, ‘save the synovium, save the joint’.”
Dr Bob Peters
MCKINLAY & PETERS EQUINE HOSPITAL - NEWMAN LAKE, WA
"In my opinion, it is efficacious, long-lasting and lower risk to cartilage than many alternatives."
Dr bruce Connally
Dr Bruce Connally
WYOMING EQUINE - WYOMING
"The most impressive part has been the duration of efficacy of at least one year in almost every case."
Dr Florent David
EQUINE VETERINARY MEDICAL CENTRE
– DOHA, QATAR
"Arthramid is a very potent and very safe product to use, and I recommend it to my clients and other vets"
Dr Jennifer Groon
Dr Jennifer Groon
THE FEINER EQUINE - WELLINGTON, FL
"Arthramid helps meditate lameness and, I believe, prevent further joint breakdown in these patients."
Dr Fransico Alvarez
Dr Fransico Alvarez
LONE STAR EQUINE SPORTS MEDICINE - MONTGOMERY, TX
"This innovative treatment supports improved mobility and overall performance, making it an invaluable tool for maintaining the health of equine athletes."
Dr Emma Wood
Dr Emma Wood
VETERINARIAN
"On his non gallop days he would complete 4000m of cantering daily, this is a lot of miles on his joints and I do not believe we could have kept him sound without the use of Arthramid.”
Dr Marc Koene
TIERKLINIK LÜSCHE GMBH EQUINE HOSPITAL – NORTHER GERMANY
"We have injected over a thousand horses and have found it to be very safe. It has been a major game-changer in the way we treat OA in our patients.”
Dr. Rachel Horsley
DOGWOOD VETERINARY HOSPITAL
“Arthramid should be a go-to for earlier OA management in small animals. It’s safe, long-lasting, and supports healthier joints.”
Dr. Vern Dryden
BUR OAK SPORTS MEDICINE & LAMENESS, LEXINGTON, KY
“It’s given me another tool in my arsenal to effectively manage all stages of equine osteoarthritis, especially those horses with equine metabolic disease.”
Arthramid by Contura Vet

From Human Medicine to Equine

Arthramid uses the same 2.5% iPAAG technology applied in human osteoarthritis care. This One Health approach bridges veterinary and human medicine.

This One Health approach reflects our commitment to improving the wellbeing of both animals and people, advancing joint care across species. Ongoing studies at Colorado State University continue to deepen understanding of how 2.5% iPAAG’s mechanism of action, with findings applicable across species.

LEARN MORE

Get The White Paper

This field is for validation purposes and should be left unchanged.

Secret Link